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KEY POINTS
- There is limited evidence regarding the efficacy of TCM for arthritis, yet TCM such as Chinese
herbal medicine and acupuncture is popular among arthritis patients
- Majority of TCM utilization by arthritis patients is concurrent to conventional medications and
this raises the potential of a number of direct and indirect risks
- Direct and indirect risks of TCM use within wider arthritis patient care may be exacerbated by
challenges around communication and disclosure
- We need a more sophisticated level of detail about how, when and why people use TCM for
arthritis and further empirical work on this topic is required to help inform conventional health
practitioners, policymakers, and patients to ensure safe, effective coordinated care for those
with arthritis.
Arthritis has contributed significantly to the global disability burden associated with the
musculoskeletal system (1). Comprised over 100 different diseases and conditions that affect joints,
the surrounding and other connective tissues, arthritis is a leading cause of pain, functional
disability and health services utilization in many countries (2). Moreover, arthritis is associated
with reduced workplace productivity in higher-income countries, as well as in lower- and
middle-income countries, causing subsequently worsening poverty (1). Furthermore, osteoarthritis
(OA) and rheumatoid arthritis (RA) are the two most common forms of arthritis, exposing to a
higher risk of comorbidities and mental problems, compared to the general population (3). Under
these circumstances, challenges increase in the management of arthritis for patients with arthritis,
healthcare providers and policy makers.
Traditional Chinese medicine (TCM), a comprehensive medical health system including
acupuncture, Chinese herbal medicine, Chinese therapeutic massage, Tai Chi, Qi Gong, and a
range of other health modalities has attracted increasing attention from arthritis sufferers and
healthcare providers (4). However, there is limited evidence supporting the efficacy of TCM
treatments for arthritis (5–7).While those studies appealing to a restricted evidence-base (limited to
efficacy and pursued via randomized controlled trials and other experimental designs) may dismiss
complementary medicine and TCM as irrelevant to arthritis care and investigation, a significant
number of people with arthritis do use TCM in addition to their conventional medical treatments.
Healthcare providers and patients with arthritis need to be aware of the potential direct and indirect
risks associated with the concurrent use ofmultiplemedications and practices. Indeed, the dismissal
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of complementary medicine and TCM denies a number of
important practice realities and may well prove detrimental to
the safety and quality of care provided to many with arthritis.
TCM has been developed since ancient China and has
been incorporated into the western culture. In countries such
as Australia, TCM has been recognized and registered under
Australian Practitioner Health Regulation Agency (APHRA)
and TCM has been incorporated into the 11th Revision of
International Statistical Classification of Diseases and Related
Health Problems (ICD-11) at the 72nd World Health Assembly
held in Geneva, Switzerland in 2019 (8). This consideration
and engagement partly reflects the reality of health care use in
healthcare systems among WHO member states (9). Despite the
acknowledged lack of evidence regarding efficacy for TCM use
for arthritis, coping with arthritis remains a leading reason why
US adults seek a range of complementary medicine treatments
including TCM (2). Indeed, the popularity of TCM among those
with arthritis has grown of late and the treatment of arthritis is the
leading clinical reason why patients consult acupuncturists (10).
Substantial use of TCM among those with arthritis is reason
enough to insist this topic be a core focus for public health
and health services research, yet there are other circumstances
that further spotlight the significance of investigating TCM use
for arthritis, ideally via a multi-disciplinary perspective and
approach. The majority of TCM use among those with arthritis
occurs concurrently to conventional medical treatment (2)—
a situation that introduces potential direct and indirect risks
(11). There are direct risks related with TCM use for arthritis—
regarding adverse events (e.g., itching, skin rashes, redness)
from TCM patches, as well as TCM–conventional drug reactions
(e.g., lassitude, nocturia, cold extremities) and indirect risks
associated with the quality of TCM herbs and formulations
owing to geographical or seasonal variations, as well as potential
information about practitioner variability in TCM knowledge
and communication between patients and practitioners (11).
Such risks are exacerbated by communication inefficiencies,
both between patients and practitioners and across practitioners
who may be engaged in patient care. While co-ordinated care
between healthcare providers and patients with arthritis is often
an ideal, research shows complementary medicine users tend
not to disclose to their conventional health providers (2, 12)
and conventional doctors tend not to enquire with patients
regarding possible treatments they may be utilizing beyond the
mainstream (13). A recent systematic review and meta-analysis
focusing on disclosure of TCMuse and other CAMuse tomedical
providers indicated a 33% disclosure rate (12). Such findings
appear to hold among those with arthritis and among those
who provide their conventional medical care with regards to
TCM (2).
The percentage of patients with arthritis using TCM ranges
from 7.7 to 27.3% (2, 14). In light of these circumstances, it is
imperative we know much more around how, when and why
TCM is being sought, used and communicated within arthritis
care. Indeed, further exploration of how TCM use and practice
play out in daily routine health-seeking and care for those with
arthritis is of benefit to all receiving and providing treatments,
whether TCM or conventional in nature. It is essential for
healthcare providers, particularly conventional doctors, to be
fully informed of all patient’s health-seeking information in order
to avoid potential risks and inefficiencies and ensure optimal
clinical care.
In response, there is an urgent need to broaden the research
gaze on this topic—tomove beyond a preoccupation with efficacy
and trial design and to also embrace public health and health
services research thinking and practice (15, 16). Drawing upon a
range of established disciplines such as health geography, health
psychology, epidemiology, and health sociology as well as a vast
range of associated, rigorous methods of data collection and
analyses it is possible to supplement the tight clinical focus
of emerging research on TCM in arthritis to good effect. In
a health research age where translation and implementation
are rightfully occupying much attention and scholarship (17),
a focus upon broadening perspectives and methodology should
be welcomed by all. Moreover, the ability to move ever closer
to positively changing the thinking and actions of stakeholders
with a view to better health outcomes is itself only fully realized
by such a multidisciplinary (perhaps truly transdisciplinary)
research approach.
While not wanting to prescribe specific research designs and
questions at the expense of others, a range of pertinent issues
around TCM use in arthritis can be identified that require our
urgent attention. We still know relatively little about the drivers
and barriers to better communication and disclosure between
arthritis patients and their clinicians regarding possible and/or
active TCM use. Similarly, the communication and coordination
of arthritis care across the conventional and complementary
medical practitioner divide remains uncharted territory and, at
a basic level, we still know little about the possible acceptance
and/or success of implementation strategies and interventions
with a view to improving practices and communication around
this topic. While in the immediate term the choice of which
specific areas to address may be open to debate, what is
beyond question is that TCM use among those with arthritis
is substantial, associated with a range of possible direct and
indirect risks to patient care and as a consequence requires a
broad multidisciplinary health research approach. The challenge
for all providing care is to accommodate and embrace rigorous,
scientific enquiry on this topic and to be open to at least
discussing TCM use with their patients, regardless of whether
they personally support or oppose TCM use. The bottom line
is clear—a significant number of patients are already users
of TCM for their arthritis and only through investigation
and better understanding of the behaviors, motivations and
outcome of such treatments and practices will we be able to
move toward ensuring safe, effective co-ordinated care for those
with arthritis.
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